Basic Information
LamKap Bio Group's core focus is on the research, development, and manufacturing of selected bispecific antibodies for antibody-based therapies targeting cancer and immune system diseases.
LamKap Bio Group
Zurich,Switzerland
15~50 people
January 01, 2017
info@lamkapbio.com
Enterprise Profile
Industrial Sector
Technology
Concept
Application Scenarios